EichorEICHOR
Location: Austria Synced from ClinicalTrials.gov · August 09, 2026

Clinical studies recruiting near Austria

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Nitrate, Exercise and Vascular Function in Midlife Women
NA · University of Vienna · NCT06527248
Randomized Comparison of Skeletonized Versus Pedicled Left Internal Thoracic Artery
NA · Medical University Innsbruck · NCT05931783
Observational Study Protocol: LIVER-R
Phase N/A · AstraZeneca · NCT06252753
Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure
NA · University Hospital, Geneva · NCT06207383
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Sanofi · NCT06867094
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
Phase N/A · Insel Gruppe AG, University Hospital Bern · NCT01257269
Austrian PBC Registry
Phase N/A · Medical University of Vienna · NCT07598669
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or
Phase 3 · CSL Behring · NCT07080905
A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
Phase 2/Phase 3 · University of Birmingham · NCT05991388
A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients Wit
Phase 1 · eleva GmbH · NCT07483827
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · Princess Maxima Center for Pediatric Oncology · NCT05327894
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Bristol-Myers Squibb · NCT07106762
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Merck Sharp & Dohme LLC · NCT06393374
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Pfizer · NCT06758401
Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Phase 2 · Miltenyi Biomedicine GmbH · NCT04844866
Diabetes Registry Graz for Biomarker Research
Phase N/A · Medical University of Graz · NCT05324488
XEN Glaucoma Gel Stent Versus Trabeculectomy
NA · Prof. Dr. Herbert Reitsamer · NCT05439161
Predication of Arterial Stiffness in Healthy Adults by Oral Health and Chewing Assessments
NA · VASCage GmbH · NCT07736222
The Effect of Psychoeducational Diagnosis Communication on Perception of Illness, Satisfaction, and Behavioral Intention
NA · Medical University of Graz · NCT07588282
Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
Phase 3 · Vastra Gotaland Region · NCT06419946
The DRAGON 2 Trial
NA · Maastricht University · NCT05428735
Smartphone Based Digital Screening for Aortic Valve Stenosis
Phase N/A · Medical University Innsbruck · NCT07284550
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Phase 3 · ADARx Pharmaceuticals, Inc. · NCT06960213
Safety and Early Efficacy of Radical Prostatectomy for Newly Diagnosed Very High Risk Locally Advanced and Oligometastat
NA · Medical University of Vienna · NCT02971358
First-In-Human Clinical Study for Treatment of Severe Mitral Valve INsufficiency With Epygon™ TRanscatheter Mitral VAlve
NA · Epygon · NCT04775108
The Medacta International SMS Post-Marketing Surveillance Study
Phase N/A · Medacta International SA · NCT02748408
Exercise Intensity and Muscle Recovery in Statin Users
NA · Raffaele Mazzolari · NCT07563452
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · PedAL BCU, LLC · NCT05183035
Randomization of Single vs Multiple Arterial Grafts
NA · Weill Medical College of Cornell University · NCT03217006
M-ARS ACL Post-marketing Surveillance Study
Phase N/A · Medacta International SA · NCT04462458
Look up another city
Look up another condition